HPV vaccine has reduced the need for cervical cancer screening, American Cancer Society says - The Philadelphia Inquirer

“Ensuring that individuals adhere to a five‐year screening interval poses challenges for patients, clinicians, and payers,” the guideline committee wrote in CA: A Cancer Journal for Clinicians. “For patients, keeping track of when they are due for screening may be, and likely will be, more difficult than keeping track of short‐interval testing. For clinicians, harnessing registries to monitor the screening status of all women is crucial but may be more difficult for longer interval testing.”